KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) Return on Equity (2018 - 2025)

Guardant Health (GH) has disclosed Return on Equity for 8 consecutive years, with 1.83% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 253.0% to 1.83% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.83% through Dec 2025, down 253.0% year-over-year, with the annual reading at 3.48% for FY2025, 4933.0% up from the prior year.
  • Return on Equity hit 1.83% in Q4 2025 for Guardant Health, up from 1.21% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 16.61% in Q3 2024 to a low of 85.08% in Q1 2023.
  • Historically, Return on Equity has averaged 4.82% across 5 years, with a median of 0.62% in 2022.
  • Biggest five-year swings in Return on Equity: tumbled -8440bps in 2023 and later surged 8102bps in 2024.
  • Year by year, Return on Equity stood at 0.57% in 2021, then crashed by -915bps to 5.77% in 2022, then skyrocketed by 57bps to 2.48% in 2023, then soared by 276bps to 4.37% in 2024, then plummeted by -58bps to 1.83% in 2025.
  • Business Quant data shows Return on Equity for GH at 1.83% in Q4 2025, 1.21% in Q3 2025, and 1.49% in Q2 2025.